ADAM metallopeptidase domain 12 overexpression correlates with prognosis and immune cell infiltration in clear cell renal cell carcinoma

This study investigated the role of ADAM metallopeptidase domain 12 (ADAM12) in clear cell renal cell carcinoma (ccRCC). The mRNA expression of ADAM12 was analyzed using The Cancer Genome Atlas (TCGA) database and the Gene Expression Omnibus (GEO) database, and the protein expression level of ADAM12...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Junjie, Yang, Dandan, Xu, Haonan, Yang, Kunpeng, Ma, Jia, Xia, Jun, Pan, Xueshan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8973862/
https://www.ncbi.nlm.nih.gov/pubmed/35094638
http://dx.doi.org/10.1080/21655979.2021.2010313

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8973862/
https://www.ncbi.nlm.nih.gov/pubmed/35094638
http://dx.doi.org/10.1080/21655979.2021.2010313

Ejemplares similares